Use of Postexposure Prophylaxis after Occupational Exposure to Zaire ebolavirus

Karen K. Wong; Richard T. Davey; Angela L. Hewlett; Colleen S. Kraft; Aneesh K. Mehta; Mark J. Mulligan; Allison Beck; William Dorman; Christopher J. Kratochvil; Lilin Lai; Tara N. Palmore; Susan Rogers; Philip W. Smith; Anthony F. Suffredini; Mark Wolcott; Ute Ströher; Timothy M. Uyeki

Journal ArticleOPEN ACCESS

Use of Postexposure Prophylaxis after Occupational Exposure to Zaire ebolavirus

Clinical Infectious Diseases (2016) 63(3) 376-379

DOI: 10.1093/cid/ciw256

26Citations

53Readers

Get full text

Abstract

From September 2014 to April 2015, 6 persons who had occupational exposures to Zaire ebolavirus in West Africa received investigational agent rVSV-ZEBOV or TKM-100802 for postexposure prophylaxis and were monitored in the United States. All patients experienced self-limited symptoms after postexposure prophylaxis; none developed Ebola virus disease.

Author supplied keywords

Cite

CITATION STYLE

APA

Wong, K. K., Davey, R. T., Hewlett, A. L., Kraft, C. S., Mehta, A. K., Mulligan, M. J., … Uyeki, T. M. (2016). Use of Postexposure Prophylaxis after Occupational Exposure to Zaire ebolavirus. Clinical Infectious Diseases, 63(3), 376–379. https://doi.org/10.1093/cid/ciw256

Use of Postexposure Prophylaxis after Occupational Exposure to Zaire ebolavirus

Abstract

Author supplied keywords

Cite

Register to see more suggestions